Plunkett Research Online: Anchiano Therapeutics Ltd

ANCHIANO THERAPEUTICS LTD (ANCN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Anchiano Therapeutics Ltd. is a preclinical biotechnology company that discovers and develops new cancer therapies designed to target the products of mutated genes that drive human malignancies. The firm’s therapies are small molecule targeted therapeutics, the first of which inhibits the products .....



Anchiano Therapeutics Ltd
Ticker: ANCN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 972-2-548-6555
Fax: 972-2-548-6550
Address: 5 Kiryat Hamada Street
P.O. Box 45032, Har Hotzvim
Jerusalem, 9777401 Israel

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Development & Manufacturing
Contacts Description

Frank G. Haluska CEO
Jonathan Burgin CFO
See More
Anchiano Therapeutics Ltd. is a preclinical biotechnology company that discovers and develops new cancer therapies designed to target the products of mutated genes that drive human malignancies. The firm’s therapies are small molecule targeted therapeutics, the first of which inhibits the products .....See More See More

Auditor: Somekh Chaikin
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2019 2018 2017 2016 2015 2014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: